Pomerantz LLP Announces the Settlement of Class Action Involving Securities of The Medicines Company Purchased Or Acquired Between January 8, 2013 and February 12, 2014

NEWARK, N.J., April 5, 2016 /PRNewswire/ --

UNITED STATES DISTRICT COURT
DISTRICT OF NEW JERSEY

NOTICE OF SETTLEMENT OF CLASS ACTION
AND SETTLEMENT FAIRNESS HEARING

TO:     All persons or entities who purchased or otherwise acquired the securities of The Medicines Company between January 8, 2013 and February 12, 2014.

A hearing (the "Settlement Hearing") shall be held before the Honorable Claire C. Cecchi of the District of New Jersey in the Martin Luther King Building & U.S. Courthouse, 50 Walnut Street, Courtroom 5B, Newark, New Jersey 07101, on June 7, 2016, at 10:30 a.m.. At the Settlement Hearing, the Court will consider whether: (1) to permanently certify a class (the "Class"), for settlement purposes only, consisting of all persons or entities who purchased or otherwise acquired the securities of The Medicines Company (the "Company" or "MDCO") between January 8, 2013 and February 12, 2014 (the "Class Period"); (2) to approve as fair, reasonable, and adequate the proposed settlement of this action (the "Action") in exchange for $4.25 million; (3) to dismiss with prejudice the Action and to enter judgment releasing the Released Claims against the Defendants and Released Defendant Parties; and (4) to approve the application of Lead Counsel for payment of attorneys' fees, reimbursement of costs and expenses, and payment of a Compensatory Award to the Lead Plaintiff.

If you purchased or otherwise acquired MDCO securities during the Class Period, you will be bound by the Settlement unless you send a signed letter stating (i) your name, address, and telephone number; (ii) your purchases, acquisitions, sales, and dispositions of MDCO securities during the Class Period (including the dates the number of securities purchased, acquired, or sold, and the price paid or received for each such purchase or sale); and (iii) that you "request exclusion from the Class in the MDCO Securities Litigation" by May 17, 2016 to: MDCO Securities Litigation, Claims Administrator, P.O. Box 4230, Portland-OR 97208-4230.

If you are a Class Member and do not exclude yourself, you can object to the Settlement by filing a signed letter with the Court saying that you object to the proposed Settlement in the MDCO Securities Litigation. Your objection must be filed with the Court and mailed or delivered to each of the following addresses such that it is received no later than May 17, 2016:

Any objection must: (1) include your name, address, telephone number, and signature; (2) identify the date(s), price(s), and number(s) of MDCO securities that you purchased or otherwise acquired during the Class Period; (3) provide a detailed statement of your objections to any matters before the Court; (4) include a written notice of your intention to appear at the hearing (if you intend to appear); and (5) attach all documents or writings you wish the Court to consider.

For copies of the complete settlement documents, please visit the Claims Administrator's website at www.MDCOSecuritiesLitigation.com or contact the Claims Administrator toll-free at (888) 653-7709.

Any questions regarding the Settlement should be directed to Lead Counsel. Please do not contact the Court or the Clerk's Office or Defendants' Counsel regarding this Notice.

Dated: April 5, 2016                                 BY ORDER OF THE COURT                                   
                                                              UNITED STATES DISTRICT COURT
                                                              DISTRICT OF NEW JERSEY

URL: www.MDCOSecuritiesLitigation.com

SOURCE United States District Court, District of New Jersey

Related Links

http://www.MDCOSecuritiesLitigation.com